Home
>
National Drug Code (NDC)
>
Ilaris
Ilaris - 0078-0582-61 - (canakinumab)
Drug Information of Ilaris
| Product NDC: | 0078-0582 |
| Proprietary Name: | Ilaris |
| Non Proprietary Name: | canakinumab |
| Active Ingredient(s): | 150 mg/mL & nbsp; canakinumab |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ilaris
| Product NDC: | 0078-0582 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125319 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090618 |
Package Information of Ilaris
| Package NDC: | 0078-0582-61 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0078-0582-61) > 1 mL in 1 VIAL, SINGLE-USE |
NDC Information of Ilaris
| NDC Code | 0078-0582-61 |
| Proprietary Name | Ilaris |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0078-0582-61) > 1 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0078-0582 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | canakinumab |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20090618 |
| Marketing Category Name | BLA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | CANAKINUMAB |
| Strength Number | 150 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
